- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
20296 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
1287 Participants Needed
Trial Details
Key Eligibility Criteria
3200 Participants Needed
Trial Details
Key Eligibility Criteria
1900 Participants Needed
Trial Details
Key Eligibility Criteria
700 Participants Needed
Trial Details
Key Eligibility Criteria
92 Participants Needed
Trial Details
Key Eligibility Criteria
3000 Participants Needed
Trial Details
Key Eligibility Criteria
400 Participants Needed
Trial Details
Key Eligibility Criteria
153 Participants Needed
Trial Details
Key Eligibility Criteria
481 Participants Needed
Trial Details
Key Eligibility Criteria
282 Participants Needed
Trial Details
Key Eligibility Criteria
5350 Participants Needed
Trial Details
Key Eligibility Criteria
1857 Participants Needed
Trial Details
Key Eligibility Criteria
2650 Participants Needed
Trial Details
Key Eligibility Criteria
150 Participants Needed
Trial Details
Key Eligibility Criteria
1600 Participants Needed
Trial Details
Key Eligibility Criteria
120 Participants Needed
Trial Details
Key Eligibility Criteria
248 Participants Needed
"In December 2023 I had a stent placed in an artery. I was so glad that the blockage was found before I had either a heart attack, stroke, or both. I have been on Pravastatin for as long as I can remember but I continue to have elevated cholesterol levels. I'm trying to get ahead of my condition by learning more about the latest research and drugs available."
"I have a known blockage developing in lower left main 50%, which my doctors are watching. We've considered surgery, but I'd like to rule out all possible other options first. I've done some research, which brought me to clinical trials."
"I've been diagnosed with type 2 diabetes since 2000. I was on the highest dose of metformin, which didn't work for me. In 2022, I tried Ozempic, which had bad side effects. I'm not currently on anything to treat my diabetes, given my experiences (as well as some insurance denials). I'm glad that clinical trials exist to help me try to access the latest research. I'm frustrated but also motivated."
"I have gasteroparesis which causes me extreme bloating, pain, acid reflux, occasional vomiting, nausea, and constipation. Most standard medications have not helped. I did some research to learn about investigational drugs, which I'd be excited to get to access through a trial."
"My ejection fraction is now 20-25%, quite low. Trying to optimize my medications at this time. I have had Biventricular pacemaker/ICD since 2007. I am doing everything I can to improve my health. Following a diet, exercising 30 minutes every day. Most days my systolic blood pressure is < 100. I had a L/R Cath in December and do not have any problems with my coronary arteries. I'm hoping to learn more about the latest research and drugs by participating in a trial. "
Trial Details
Key Eligibility Criteria
325 Participants Needed
Trial Details
Key Eligibility Criteria
200 Participants Needed
Trial Details
Key Eligibility Criteria
100 Participants Needed
Trial Details
Key Eligibility Criteria
4000 Participants Needed
Trial Details
Key Eligibility Criteria
549 Participants Needed
Trial Details
Key Eligibility Criteria
669 Participants Needed
Trial Details
Key Eligibility Criteria
250 Participants Needed
Trial Details
Key Eligibility Criteria
250 Participants Needed
Trial Details
Key Eligibility Criteria
152 Participants Needed
Trial Details
Key Eligibility Criteria
64 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Atrial Fibrillation trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Atrial Fibrillation is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added AI Mapping and Ablation for Atrial Fibrillation, Mobile Health Technology for Atrial Fibrillation and Farapulse Catheter System for Atrial Fibrillation to the Power online platform.